Offer - Urjas Oil for just ₹ 1 X
Duvanta NP 20 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Duvanta NP 20 Tablet safe for pregnant women?
Pregnant women can take Duvanta Np without worrying about any side effects.
Is the use of Duvanta NP 20 Tablet safe during breastfeeding?
Breastfeeding women can safely use Duvanta Np.
What is the effect of Duvanta NP 20 Tablet on the Kidneys?
Duvanta Np may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Duvanta NP 20 Tablet on the Liver?
Duvanta Np is rarely harmful for the liver.
What is the effect of Duvanta NP 20 Tablet on the Heart?
Duvanta Np has very mild side effects on the heart.
Duvanta NP 20 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Duvanta NP 20 Tablet unless your doctor advises you to do so -
Is this Duvanta NP 20 Tablet habit forming or addictive?
Forming a habit of Duvanta NP 20 Tablet has not been reported.
Interaction between Food and Duvanta NP 20 Tablet
Eating certain foods may increase the time it takes Duvanta NP 20 Tablet to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Duvanta NP 20 Tablet
Information about the interaction of Duvanta NP 20 Tablet and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 474-475
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 462
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cymbalta (duloxetine hydrochloride)